Chromophobe Renal Cell Carcinoma (2)

Papillary Renal Cell Carcinoma Type 1 (2)

Papillary Renal Cell Carcinoma Type 2 (2)

Renal Cell Carcinoma (2)

Sarcomatoid Renal Cell Carcinoma (2)

Xp11 Translocation Carcinoma (1)

Xp11.2 Translocation-Related Renal Cell Carcinoma (1)

Active, not recruiting (1)

Recruiting (1)

phase 2 (2)

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (2)

Bristol-Myers Squibb (1)

cabozantinib (1)

ipilimumab (1)

nivolumab (1)

drug (2)

Other (2)

Interventional (2)

papillary renal cell carcinoma type 1

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Feb 14, 2022

Recruiting

Feb 14, 2022